ekonominyheter

TranslateRSSMobil
For Allergan Suitors, Unorthodox Alliance Proved Unwieldy

For Allergan Suitors, Unorthodox Alliance Proved Unwieldy

Wall Street Journal 19/11 21:58

A look at the partnership of Valeant CEO Michael Pearson and activist investor William Ackman in their failed $53 billion bid to acquire Allergan shows that the two men didn?t always see eye to eye.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status